Simple but effective comparasin thefitter...I like it.
There is one factor that people who, somewhat naively in my opinion, think that Nasdaq listing is already factored in or will have minimal effect on SP may have overlooked.
That is the fact that NO SHARES HAVE YET BEEN PURCHASED FOR NASDAQ LISTING!!! This IMO changes the whole ball game come Nasdaq listing time. Because they have to effectivley buy their shares on the ASX, but in chunks of 30 shares at a time, this will build the volumes traded MASSIVLEY, and the traders will be left high and dry!
I am envisioning the prospect of very few shares actually being available for sale in the weeks/months after we list...and the SP consequenses this will have.
We already know there has been huge investor interest in PRR shares, and the immunotherapy sector is getting hotter by the day!
Am I dreaming...or can anyone else see this scenario playing out??? Love to know what others think???
hypothtical sp, page-2
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73996 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 836970 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |